Interested in learning how nanomedicine is used to detect and treat cancer? Want to get involved in developing new nanotechnologies for the clinic? We are looking to match undergrads at Northeastern University with leading Boston researchers and clinicians for a six-month, hands-on research experience. If you are thinking about a career in cancer science, engineering, or medicine, come get involved in the world’s first undergraduate program in cancer nanomedicine! We have 8 upcoming openings for the January – June 2018 co-op period. We will be accepting applications starting in September 2017 via NUcareers.
CaNCURE Co-op Showcase
The CaNCURE Team would like to send out a congratulations to the 7 trainees who completed their CaNCURE co-op this June! We were so proud to see all your accomplishments at our third annual CaNCURE Nanomedicine Day and to learn that for many of you, this co-op was a career-defining experience!
Darrel J Irvine, Ph.D.
Professor of Materials Science & Engineering , MIT
Our laboratory has had a long-standing interest in use of engineered materials for enhancing cancer immunotherapy. Students will study how nanoparticle-based vaccines can control where and how cells of the immune system respond to tumor cells, with the goal of overcoming immunosuppression in solid tumors.
Bryan Spring, Ph.D.
Assistant Professor, NEU
The ultimate goal of the program is to reduce cancer recurrence and mortality by establishing new approaches for personalized medicine that address tumor heterogeneity, drug-resistance and molecular mechanisms of treatment escape. Advanced-stage cancer patients are presently subjected to a grueling treatment regimen consisting of surgical tumor debulking and high-dose-intensity chemotherapy. These standard approaches frequently hit a wall due to dose-limiting toxicities as well as mechanisms of drug-resistance and treatment escape via cell signaling networks.
Analysis of DREAM and E2F1 Competition for Cell Cycle Promoters during G1.
Health Science, '18
Delivery of Titanium Dioxide Nanoparticles via Biodegradable PLGA Dissolving Microneedles for Sustainable Release
Chemical Engineering, '19
In vivo imaging of targeted drug delivery to HER2 positive cancer cells